{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:04:07Z","timestamp":1793829847334,"version":"4.6.1"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM144137"],"award-info":[{"award-number":["R35GM144137"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32GM131963"],"award-info":[{"award-number":["T32GM131963"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000928","name":"Welch Foundation","doi-asserted-by":"publisher","award":["I-1532"],"award-info":[{"award-number":["I-1532"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP150053"],"award-info":[{"award-number":["RP150053"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP170170"],"award-info":[{"award-number":["RP170170"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP210041"],"award-info":[{"award-number":["RP210041"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000194","name":"U.S. Department of State","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000194","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G0E6517N"],"award-info":[{"award-number":["G0E6517N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Chem Biol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1038\/s41589-025-02058-0","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T10:02:45Z","timestamp":1763719365000},"page":"2002-2013","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["SINE compounds activate exportin 1 degradation through an allosteric mechanism"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6437-0129","authenticated-orcid":false,"given":"Casey E.","family":"Wing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0502-1957","authenticated-orcid":false,"given":"Ho Yee Joyce","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4459-5299","authenticated-orcid":false,"given":"Bert","family":"Kwanten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0256-7636","authenticated-orcid":false,"given":"Tolga","family":"Cagatay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0118-7483","authenticated-orcid":false,"given":"Ashley B.","family":"Niesman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2626-4189","authenticated-orcid":false,"given":"Maarten","family":"Jacquemyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8030-3121","authenticated-orcid":false,"given":"Mehdi","family":"Gharghabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5353-0919","authenticated-orcid":false,"given":"Brecht","family":"Permentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binita","family":"Shakya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7907-7195","authenticated-orcid":false,"given":"Rhituparna","family":"Nandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1305-9581","authenticated-orcid":false,"given":"Joseph M.","family":"Ready","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinayan","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Shacham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosef","family":"Landesman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6916-9400","authenticated-orcid":false,"given":"Rosa","family":"Lapalombella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7092-1153","authenticated-orcid":false,"given":"Dirk","family":"Daelemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4974-0726","authenticated-orcid":false,"given":"Yuh Min","family":"Chook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"2058_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41580-021-00446-7","volume":"23","author":"CE Wing","year":"2022","unstructured":"Wing, C. E., Fung, H. Y. J. & Chook, Y. M. Karyopherin-mediated nucleocytoplasmic transport. Nat. Rev. Mol. Cell Biol. 23, 307\u2013328 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2058_CR2","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1126\/science.1173388","volume":"324","author":"T Monecke","year":"2009","unstructured":"Monecke, T. et al. Crystal structure of the nuclear export receptor CRM1 in complex with Snurportin1 and RanGTP. Science 324, 1087\u20131091 (2009).","journal-title":"Science"},{"key":"2058_CR3","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.str.2013.06.003","volume":"21","author":"C Dian","year":"2013","unstructured":"Dian, C. et al. Structure of a truncation mutant of the nuclear export factor CRM1 provides insights into the auto-inhibitory role of its C-terminal helix. Structure 21, 1338\u20131349 (2013).","journal-title":"Structure"},{"key":"2058_CR4","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1038\/emboj.2010.89","volume":"29","author":"M Koyama","year":"2010","unstructured":"Koyama, M. & Matsuura, Y. An allosteric mechanism to displace nuclear export cargo from CRM1 and RanGTP by RanBP1. EMBO J. 29, 2002\u20132013 (2010).","journal-title":"EMBO J."},{"key":"2058_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41571-020-00442-4","volume":"18","author":"AS Azmi","year":"2021","unstructured":"Azmi, A. S., Uddin, M. H. & Mohammad, R. M. The nuclear export protein XPO1\u2014from biology to targeted therapy. Nat. Rev. Clin. Oncol. 18, 152\u2013169 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2058_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-014-0078-0","volume":"7","author":"K Parikh","year":"2014","unstructured":"Parikh, K., Cang, S., Sekhri, A. & Liu, D. Selective inhibitors of nuclear export (SINE)\u2014a novel class of anti-cancer agents. J. Hematol. Oncol. 7, 78 (2014).","journal-title":"J. Hematol. Oncol."},{"key":"2058_CR7","doi-asserted-by":"publisher","first-page":"9487","DOI":"10.1016\/j.bmc.2008.09.051","volume":"16","author":"T Van Neck","year":"2008","unstructured":"Van Neck, T. et al. Inhibition of the CRM1-mediated nucleocytoplasmic transport by N-azolylacrylates: structure\u2013activity relationship and mechanism of action. Bioorg. Med. Chem. 16, 9487\u20139497 (2008).","journal-title":"Bioorg. Med. Chem."},{"key":"2058_CR8","doi-asserted-by":"publisher","first-page":"14440","DOI":"10.1073\/pnas.212285299","volume":"99","author":"D Daelemans","year":"2002","unstructured":"Daelemans, D. et al. A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear export. Proc. Natl Acad. Sci. USA 99, 14440\u201314445 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2058_CR9","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1038\/leu.2016.136","volume":"30","author":"ZA Hing","year":"2016","unstructured":"Hing, Z. A. et al. Next-generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematological malignancies. Leukemia 30, 2364\u20132372 (2016).","journal-title":"Leukemia"},{"key":"2058_CR10","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1007\/s40265-019-01188-9","volume":"79","author":"YY Syed","year":"2019","unstructured":"Syed, Y. Y. Selinexor: first global approval. Drugs 79, 1485\u20131494 (2019).","journal-title":"Drugs"},{"key":"2058_CR11","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1158\/1078-0432.CCR-16-1580","volume":"23","author":"T Vercruysse","year":"2017","unstructured":"Vercruysse, T. et al. The second-generation exportin-1 inhibitor KPT-8602 demonstrates potent activity against acute lymphoblastic leukemia. Clin. Cancer Res. 23, 2528\u20132541 (2017).","journal-title":"Clin. Cancer Res."},{"key":"2058_CR12","doi-asserted-by":"publisher","first-page":"4621","DOI":"10.1182\/blood-2012-05-429506","volume":"120","author":"R Lapalombella","year":"2012","unstructured":"Lapalombella, R. et al. Selective inhibitors of nuclear export show that CRM1\/XPO1 is a target in chronic lymphocytic leukemia. Blood 120, 4621\u20134634 (2012).","journal-title":"Blood"},{"key":"2058_CR13","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1073\/pnas.1217203110","volume":"110","author":"Q Sun","year":"2013","unstructured":"Sun, Q. et al. Nuclear export inhibition through covalent conjugation and hydrolysis of leptomycin B by CRM1. Proc. Natl Acad. Sci. USA 110, 1303\u20131308 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2058_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/leu.2012.219","volume":"27","author":"J Etchin","year":"2013","unstructured":"Etchin, J. et al. Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells. Leukemia 27, 66\u201374 (2013).","journal-title":"Leukemia"},{"key":"2058_CR15","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nn.3953","volume":"18","author":"JD Haines","year":"2015","unstructured":"Haines, J. D. et al. Nuclear export inhibitors avert progression in preclinical models of inflammatory demyelination. Nat. Neurosci. 18, 511\u2013520 (2015).","journal-title":"Nat. Neurosci."},{"key":"2058_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13045-021-01032-2","volume":"14","author":"JS Walker","year":"2021","unstructured":"Walker, J. S. et al. Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemia. J. Hematol. Oncol. 14, 17 (2021).","journal-title":"J. Hematol. Oncol."},{"key":"2058_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.chembiol.2014.11.015","volume":"22","author":"JE Neggers","year":"2015","unstructured":"Neggers, J. E. et al. Identifying drug-target selectivity of small-molecule CRM1\/XPO1 inhibitors by CRISPR\/Cas9 genome editing. Chem. Biol. 22, 107\u2013116 (2015).","journal-title":"Chem. Biol."},{"key":"2058_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/leu.2013.115","volume":"28","author":"YT Tai","year":"2014","unstructured":"Tai, Y. T. et al. CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications. Leukemia 28, 155\u2013165 (2014).","journal-title":"Leukemia"},{"key":"2058_CR19","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1182\/blood-2012-04-423160","volume":"120","author":"P Ranganathan","year":"2012","unstructured":"Ranganathan, P. et al. Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia. Blood 120, 1765\u20131773 (2012).","journal-title":"Blood"},{"key":"2058_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/srep16077","volume":"5","author":"AS Azmi","year":"2015","unstructured":"Azmi, A. S. et al. Targeting the nuclear export protein XPO1\/CRM1 reverses epithelial to mesenchymal transition. Sci. Rep. 5, 16077 (2015).","journal-title":"Sci. Rep."},{"key":"2058_CR21","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1158\/1535-7163.MCT-14-0064","volume":"13","author":"N Saito","year":"2014","unstructured":"Saito, N. et al. CBS9106-induced CRM1 degradation is mediated by Cullin RING ligase activity and the neddylation pathway. Mol. Cancer Ther. 13, 3013\u20133023 (2014).","journal-title":"Mol. Cancer Ther."},{"key":"2058_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114305","volume":"160","author":"B Kwanten","year":"2023","unstructured":"Kwanten, B. et al. E3 ubiquitin ligase ASB8 promotes selinexor-induced proteasomal degradation of XPO1. Biomed. Pharmacother. 160, 114305 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"2058_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089848","volume":"9","author":"S Wang","year":"2014","unstructured":"Wang, S., Han, X., Wang, J., Yao, J. & Shi, Y. Antitumor effects of a novel chromosome region maintenance 1 (CRM1) inhibitor on non-small cell lung cancer cells in vitro and in mouse tumor xenografts. PLoS ONE 9, e89848 (2014).","journal-title":"PLoS ONE"},{"key":"2058_CR24","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/S0006-291X(02)02971-6","volume":"300","author":"Y Liu","year":"2003","unstructured":"Liu, Y. et al. Molecular cloning and characterization of the human ASB-8 gene encoding a novel member of ankyrin repeat and SOCS box containing protein family. Biochem. Biophys. Res. Commun. 300, 972\u2013979 (2003).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2058_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16499-9","volume":"11","author":"RJ Lumpkin","year":"2020","unstructured":"Lumpkin, R. J., Baker, R. W., Leschziner, A. E. & Komives, E. A. Structure and dynamics of the ASB9 CUL-RING E3 ligase. Nat. Commun. 11, 2866 (2020).","journal-title":"Nat. Commun."},{"key":"2058_CR26","doi-asserted-by":"publisher","first-page":"6796","DOI":"10.1016\/j.febslet.2005.11.016","volume":"579","author":"J Kohroki","year":"2005","unstructured":"Kohroki, J., Nishiyama, T., Nakamura, T. & Masuho, Y. ASB proteins interact with Cullin5 and RBX2 to form E3 ubiquitin ligase complexes. FEBS Lett. 579, 6796\u20136802 (2005).","journal-title":"FEBS Lett."},{"key":"2058_CR27","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.RA120.002414","volume":"20","author":"RJ Lumpkin","year":"2021","unstructured":"Lumpkin, R. J., Ahmad, A. S., Blake, R., Condon, C. J. & Komives, E. A. The mechanism of NEDD8 activation of CUL5 ubiquitin E3 ligases. Mol. Cell Proteom. 20, 100019 (2021).","journal-title":"Mol. Cell Proteom."},{"key":"2058_CR28","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/s41589-021-00858-8","volume":"17","author":"S Kostrhon","year":"2021","unstructured":"Kostrhon, S. et al. CUL5\u2013ARIH2 E3\u2013E3 ubiquitin ligase structure reveals cullin-specific NEDD8 activation. Nat. Chem. Biol. 17, 1075\u20131083 (2021).","journal-title":"Nat. Chem. Biol."},{"key":"2058_CR29","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jmb.2012.11.014","volume":"425","author":"N Saito","year":"2013","unstructured":"Saito, N. & Matsuura, Y. A 2.1-\u00c5-resolution crystal structure of unliganded CRM1 reveals the mechanism of autoinhibition. J. Mol. Biol. 425, 350\u2013364 (2013).","journal-title":"J. Mol. Biol."},{"key":"2058_CR30","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1073\/pnas.1215214110","volume":"110","author":"T Monecke","year":"2013","unstructured":"Monecke, T. et al. Structural basis for cooperativity of CRM1 export complex formation. Proc. Natl Acad. Sci. USA 110, 960\u2013965 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2058_CR31","doi-asserted-by":"publisher","first-page":"7545","DOI":"10.1021\/acs.jmedchem.0c00143","volume":"63","author":"A Shaikhqasem","year":"2020","unstructured":"Shaikhqasem, A., Dickmanns, A., Neumann, P. & Ficner, R. Characterization of inhibition reveals distinctive properties for human and Saccharomyces cerevisiae CRM1. J. Med. Chem. 63, 7545\u20137558 (2020).","journal-title":"J. Med. Chem."},{"key":"2058_CR32","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1107\/S0907444913011220","volume":"69","author":"YK Kim","year":"2013","unstructured":"Kim, Y. K. et al. Structural basis of intersubunit recognition in elongin BC\u2013Cullin 5\u2013SOCS box ubiquitin\u2013protein ligase complexes. Acta Crystallogr. D Biol. Crystallogr. 69, 1587\u20131597 (2013).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"2058_CR33","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.cell.2008.07.022","volume":"134","author":"DM Duda","year":"2008","unstructured":"Duda, D. M. et al. Structural insights into NEDD8 activation of Cullin-RING ligases: conformational control of conjugation. Cell 134, 995\u20131006 (2008).","journal-title":"Cell"},{"key":"2058_CR34","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1091\/mbc.E18-02-0096","volume":"29","author":"SC Fu","year":"2018","unstructured":"Fu, S. C., Fung, H. Y. J., Cagatay, T., Baumhardt, J. & Chook, Y. M. Correlation of CRM1\u2013NES affinity with nuclear export activity. Mol. Biol. Cell 29, 2037\u20132044 (2018).","journal-title":"Mol. Biol. Cell"},{"key":"2058_CR35","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/ajh.24451","volume":"91","author":"F Jardin","year":"2016","unstructured":"Jardin, F. et al. Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma. Am. J. Hematol. 91, 923\u2013930 (2016).","journal-title":"Am. J. Hematol."},{"key":"2058_CR36","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1182\/blood.V128.22.972.972","volume":"128","author":"ZA Hing","year":"2016","unstructured":"Hing, Z. A. et al. Exploring the role of the recurrent exportin 1 (XPO1\/CRM1) mutations E571G and E571K in chronic lymphocytic leukemia. Blood 128, 972 (2016).","journal-title":"Blood"},{"key":"2058_CR37","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/hon.2570","volume":"37","author":"A Navarro-Bailon","year":"2019","unstructured":"Navarro-Bailon, A. et al. Exportin-1 E571K mutation is a common finding in patients with classical Hodgkin lymphoma. Hematol. Oncol. 37, 215\u2013218 (2019).","journal-title":"Hematol. Oncol."},{"key":"2058_CR38","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1038\/nature07975","volume":"458","author":"X Dong","year":"2009","unstructured":"Dong, X. et al. Structural basis for leucine-rich nuclear export signal recognition by CRM1. Nature 458, 1136\u20131141 (2009).","journal-title":"Nature"},{"key":"2058_CR39","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.celrep.2015.09.042","volume":"13","author":"SA Port","year":"2015","unstructured":"Port, S. A. et al. Structural and functional characterization of CRM1\u2013Nup214 interactions reveals multiple FG-binding sites involved in nuclear export. Cell Rep. 13, 690\u2013702 (2015).","journal-title":"Cell Rep."},{"key":"2058_CR40","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.celrep.2014.09.052","volume":"9","author":"M Koyama","year":"2014","unstructured":"Koyama, M., Shirai, N. & Matsuura, Y. Structural insights into how Yrb2p accelerates the assembly of the Xpo1p nuclear export complex. Cell Rep. 9, 983\u2013995 (2014).","journal-title":"Cell Rep."},{"key":"2058_CR41","doi-asserted-by":"publisher","first-page":"e23961","DOI":"10.7554\/eLife.23961","volume":"6","author":"HY Fung","year":"2017","unstructured":"Fung, H. Y., Fu, S. C. & Chook, Y. M. Nuclear export receptor CRM1 recognizes diverse conformations in nuclear export signals. eLife 6, e23961 (2017).","journal-title":"eLife"},{"key":"2058_CR42","doi-asserted-by":"publisher","first-page":"e10034","DOI":"10.7554\/eLife.10034","volume":"4","author":"HY Fung","year":"2015","unstructured":"Fung, H. Y., Fu, S. C., Brautigam, C. A. & Chook, Y. M. Structural determinants of nuclear export signal orientation in binding to exportin CRM1. eLife 4, e10034 (2015).","journal-title":"eLife"},{"key":"2058_CR43","doi-asserted-by":"publisher","first-page":"6596","DOI":"10.1021\/acs.jmedchem.0c01675","volume":"64","author":"Y Lei","year":"2021","unstructured":"Lei, Y. et al. Structure-guided design of the first noncovalent small-molecule inhibitor of CRM1. J. Med. Chem. 64, 6596\u20136607 (2021).","journal-title":"J. Med. Chem."},{"key":"2058_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28507-1","volume":"13","author":"S Cao","year":"2022","unstructured":"Cao, S. et al. Defining molecular glues with a dual-nanobody cannabidiol sensor. Nat. Commun. 13, 815 (2022).","journal-title":"Nat. Commun."},{"key":"2058_CR45","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1146\/annurev-pharmtox-010715-103507","volume":"57","author":"DP Bondeson","year":"2017","unstructured":"Bondeson, D. P. & Crews, C. M. Targeted protein degradation by small molecules. Annu. Rev. Pharmacol. Toxicol. 57, 107\u2013123 (2017).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"2058_CR46","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41589-019-0411-6","volume":"16","author":"DE Bussiere","year":"2020","unstructured":"Bussiere, D. E. et al. Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complex. Nat. Chem. Biol. 16, 15\u201323 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"2058_CR47","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41586-020-2374-x","volume":"585","author":"M Slabicki","year":"2020","unstructured":"Slabicki, M. et al. The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K. Nature 585, 293\u2013297 (2020).","journal-title":"Nature"},{"key":"2058_CR48","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41586-024-07089-6","volume":"627","author":"O Hsia","year":"2024","unstructured":"Hsia, O. et al. Targeted protein degradation via intramolecular bivalent glues. Nature 627, 204\u2013211 (2024).","journal-title":"Nature"},{"key":"2058_CR49","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1038\/s41589-024-01668-4","volume":"20","author":"YD Li","year":"2024","unstructured":"Li, Y. D. et al. Template-assisted covalent modification underlies activity of covalent molecular glues. Nat. Chem. Biol. 20, 1640\u20131649 (2024).","journal-title":"Nat. Chem. Biol."},{"key":"2058_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1936-z","volume":"15","author":"GL Gravina","year":"2015","unstructured":"Gravina, G. L. et al. KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin [corrected] in prostate cancer models. BMC Cancer 15, 941 (2015).","journal-title":"BMC Cancer"},{"key":"2058_CR51","doi-asserted-by":"publisher","first-page":"22202","DOI":"10.1074\/jbc.M110.131821","volume":"285","author":"M Hilliard","year":"2010","unstructured":"Hilliard, M. et al. The anti-inflammatory prostaglandin 15-deoxy-delta(12,14)-PGJ2 inhibits CRM1-dependent nuclear protein export. J. Biol. Chem. 285, 22202\u201322210 (2010).","journal-title":"J. Biol. Chem."},{"key":"2058_CR52","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01325-23","volume":"97","author":"P Ribo-Molina","year":"2023","unstructured":"Ribo-Molina, P. et al. 4-Octyl itaconate reduces influenza A replication by targeting the nuclear export protein CRM1. J. Virol. 97, e0132523 (2023).","journal-title":"J. Virol."},{"key":"2058_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011506","volume":"19","author":"FH Waqas","year":"2023","unstructured":"Waqas, F. H., et al. NRF2 activators inhibit influenza A virus replication by interfering with nucleo-cytoplasmic export of viral RNPs in an NRF2-independent manner. PLoS Pathog. 19, e1011506 (2023).","journal-title":"PLoS Pathog."},{"key":"2058_CR54","doi-asserted-by":"publisher","unstructured":"Waqas, F. H. et al. NRF2 activators restrict coronaviruses by targeting a network involving ACE2, TMPRSS2, and XPO1. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.02.24.639813 (2025).","DOI":"10.1101\/2025.02.24.639813"},{"key":"2058_CR55","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.1242\/jcs.057026","volume":"122","author":"P Wang","year":"2009","unstructured":"Wang, P. et al. Repression of classical nuclear export by S-nitrosylation of CRM1. J. Cell Sci. 122, 3772\u20133779 (2009).","journal-title":"J. Cell Sci."},{"key":"2058_CR56","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.ebiom.2015.07.041","volume":"2","author":"E Boons","year":"2015","unstructured":"Boons, E. et al. Human exportin-1 is a target for combined therapy of HIV and AIDS related lymphoma. EBioMedicine 2, 1102\u20131113 (2015).","journal-title":"EBioMedicine"},{"key":"2058_CR57","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1158\/1538-7445.AM2023-1652","volume":"83","author":"J Van Hauwenhuyse","year":"2023","unstructured":"Van Hauwenhuyse, J. et al. Abstract 1652: a novel reversible inhibitor of XPO1 with potent efficacy in multiple preclinical mouse models. Cancer Res. 83, 1652 (2023).","journal-title":"Cancer Res."},{"key":"2058_CR58","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S1470-2045(15)00464-7","volume":"17","author":"MA Dimopoulos","year":"2016","unstructured":"Dimopoulos, M. A. et al. Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study. Lancet Oncol. 17, 27\u201338 (2016).","journal-title":"Lancet Oncol."},{"key":"2058_CR59","doi-asserted-by":"publisher","first-page":"78896","DOI":"10.18632\/oncotarget.12969","volume":"7","author":"JG Turner","year":"2016","unstructured":"Turner, J. G. et al. XPO1 inhibitor combination therapy with bortezomib or carfilzomib induces nuclear localization of I\u03baB\u03b1 and overcomes acquired proteasome inhibitor resistance in human multiple myeloma. Oncotarget 7, 78896\u201378909 (2016).","journal-title":"Oncotarget"},{"key":"2058_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101114","volume":"14","author":"B Galinski","year":"2021","unstructured":"Galinski, B. et al. XPO1 inhibition with selinexor synergizes with proteasome inhibition in neuroblastoma by targeting nuclear export of IkB. Transl. Oncol. 14, 101114 (2021).","journal-title":"Transl. Oncol."},{"key":"2058_CR61","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671\u2013675 (2012).","journal-title":"Nat. Methods"},{"key":"2058_CR62","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/978-1-0716-2337-4_16","volume":"2502","author":"HYJ Fung","year":"2022","unstructured":"Fung, H. Y. J. & Chook, Y. M. Binding affinity measurement of nuclear export signal peptides to their exporter CRM1. Methods Mol. Biol. 2502, 245\u2013256 (2022).","journal-title":"Methods Mol. Biol."},{"key":"2058_CR63","doi-asserted-by":"publisher","first-page":"5066","DOI":"10.1021\/ac3007522","volume":"84","author":"S Keller","year":"2012","unstructured":"Keller, S. et al. High-precision isothermal titration calorimetry with automated peak-shape analysis. Anal. Chem. 84, 5066\u20135073 (2012).","journal-title":"Anal. Chem."},{"key":"2058_CR64","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1110\/ps.062558507","volume":"16","author":"JC Houtman","year":"2007","unstructured":"Houtman, J. C. et al. Studying multisite binary and ternary protein interactions by global analysis of isothermal titration calorimetry data in SEDPHAT: application to adaptor protein complexes in cell signaling. Protein Sci. 16, 30\u201342 (2007).","journal-title":"Protein Sci."},{"key":"2058_CR65","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/bs.mie.2015.05.001","volume":"562","author":"CA Brautigam","year":"2015","unstructured":"Brautigam, C. A. Calculations and publication-quality illustrations for analytical ultracentrifugation data. Methods Enzymol. 562, 109\u2013133 (2015).","journal-title":"Methods Enzymol."},{"key":"2058_CR66","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nbt.3437","volume":"34","author":"JG Doench","year":"2016","unstructured":"Doench, J. G. et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR\u2013Cas9. Nat. Biotechnol. 34, 184\u2013191 (2016).","journal-title":"Nat. Biotechnol."},{"key":"2058_CR67","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783\u2013784 (2014).","journal-title":"Nat. Methods"},{"key":"2058_CR68","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","volume":"152","author":"DN Mastronarde","year":"2005","unstructured":"Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36\u201351 (2005).","journal-title":"J. Struct. Biol."},{"key":"2058_CR69","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"2058_CR70","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/s41592-019-0575-8","volume":"16","author":"T Bepler","year":"2019","unstructured":"Bepler, T. et al. Positive-unlabeled convolutional neural networks for particle picking in cryo-electron micrographs. Nat. Methods 16, 1153\u20131160 (2019).","journal-title":"Nat. Methods"},{"key":"2058_CR71","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF chimera\u2014a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"2058_CR72","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70\u201382 (2021).","journal-title":"Protein Sci."},{"key":"2058_CR73","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"2058_CR74","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1107\/S2059798318002425","volume":"74","author":"TI Croll","year":"2018","unstructured":"Croll, T. I. ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps. Acta Crystallogr. D Struct. Biol. 74, 519\u2013530 (2018).","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"2058_CR75","doi-asserted-by":"publisher","first-page":"A390","DOI":"10.1107\/S0108767318096101","volume":"74","author":"P Emsley","year":"2018","unstructured":"Emsley, P. New tools for ligand refinement and validation in Coot and CCP4. Acta Crystallogr. A Found. Adv. 74, A390 (2018).","journal-title":"Acta Crystallogr. A Found. Adv."},{"key":"2058_CR76","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/s42003-021-02399-1","volume":"4","author":"R Sanchez-Garcia","year":"2021","unstructured":"Sanchez-Garcia, R. et al. DeepEMhancer: a deep learning solution for cryo-EM volume post-processing. Commun. Biol. 4, 874 (2021).","journal-title":"Commun. Biol."},{"key":"2058_CR77","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","volume":"372","author":"E Krissinel","year":"2007","unstructured":"Krissinel, E. & Henrick, K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774\u2013797 (2007).","journal-title":"J. Mol. Biol."},{"key":"2058_CR78","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski, R. A. & Swindells, M. B. LigPlot+: multiple ligand\u2013protein interaction diagrams for drug discovery. J. Chem. Inf. Model. 51, 2778\u20132786 (2011).","journal-title":"J. Chem. Inf. Model."},{"key":"2058_CR79","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/pro.3280","volume":"27","author":"E Jurrus","year":"2018","unstructured":"Jurrus, E. et al. Improvements to the APBS biomolecular solvation software suite. Protein Sci. 27, 112\u2013128 (2018).","journal-title":"Protein Sci."},{"key":"2058_CR80","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/978-1-0716-2337-4_19","volume":"2502","author":"HYJ Fung","year":"2022","unstructured":"Fung, H. Y. J. & Chook, Y. M. Crystallization of nuclear export signals or small-molecule inhibitors bound to nuclear exporter CRM1. Methods Mol. Biol. 2502, 285\u2013297 (2022).","journal-title":"Methods Mol. Biol."},{"key":"2058_CR81","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1107\/S0907444909029436","volume":"65","author":"NW Moriarty","year":"2009","unstructured":"Moriarty, N. W., Grosse-Kunstleve, R. W. & Adams, P. D. Electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation. Acta Crystallogr. D Biol. Crystallogr. 65, 1074\u20131080 (2009).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"2058_CR82","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1107\/S0907444912001308","volume":"68","author":"PV Afonine","year":"2012","unstructured":"Afonine, P. V. et al. Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr. D Biol. Crystallogr. 68, 352\u2013367 (2012).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"2058_CR83","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"2058_CR84","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1021\/ja00220a039","volume":"110","author":"ME Jung","year":"1988","unstructured":"Jung, M. E. & Buszek, K. R. The stereochemistry of addition of trialkylammonium and pyridinium tetrafluoroborate salts to activated acetylenes. Preparation of novel dienophiles for Diels\u2013Alder reactions. JACS 110, 3965\u20133969 (1988).","journal-title":"JACS"},{"key":"2058_CR85","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/s42003-024-07237-8","volume":"7","author":"T Vercruysse","year":"2024","unstructured":"Vercruysse, T. et al. Ibetazol, a novel inhibitor of importin \u03b21-mediated nuclear import. Commun. Biol. 7, 1560 (2024).","journal-title":"Commun. Biol."}],"container-title":["Nature Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41589-025-02058-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-025-02058-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-025-02058-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T04:02:22Z","timestamp":1763956942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41589-025-02058-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":85,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2058"],"URL":"https:\/\/doi.org\/10.1038\/s41589-025-02058-0","relation":{},"ISSN":["1552-4450","1552-4469"],"issn-type":[{"value":"1552-4450","type":"print"},{"value":"1552-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"22 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y.M.C. was a consultant to and holds equity options in Karyopharm Therapeutics. Y.M.C. is also a consultant to Telo Therapeutics. B.K., M.J., B.P. and D.D. are employees of KU Leuven, which has a license agreement on KPT-SINE\u2013XPO1 inhibitors. Y.L. was an employee of Karyopharm Therapeutics and still retains ownership of company shares. S.S. is a former employee of Karyopharm Therapeutics, holds patents (8999996, 9079865, 9714226, PCT\/US12\/048319 and I574957) on hydrazide-containing nuclear transport modulators and uses and holds pending patents (PCT\/US12\/048319, 499\/2012, PI20102724 and 2012000928) on hydrazide-containing nuclear transport modulators and uses. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}